Work

The role of microbiota in the pathogenesis of schizophrenia and major depressive disorder and the possibility of targeting microbiota as a treatment option

Year: 2017
Type: review
Abstract: // Fengli Lv 1, * , Suling Chen 2, * , Lina Wang 3, * , Ronghuan Jiang 4 , Hongjun Tian 3 , Jie Li 3 , Yudong Yao 5 and Chuanjun Zhuo 2, 3 1 The department of rehabilition, The Second Affiliated Hosptial of Tianjin Medical University, Tianjin, China 2 Department of Psychiatry, Wenzhou Seventh People’s Hospital, Wenzhou, Zhejiang, China 3 Department of Psychiatry, Tianjin Anding Hospital, Tianjin Mental Health Center, Tianjin, China 4 Department of Psychological Medicine, Chinese People’s Liberation Army, General Hospital, Chinese People’s Liberation Army Medical School, Beijing, China 5 Department of Pharmacology and Physiology, SUNY Downstate Medical Center, Brooklyn, NY, USA * These authors contributed equally to this work Correspondence to: Chuanjun Zhuo, email: [email protected] Yudong Yao, email: [email protected] Jie Li, email: [email protected] Keywords: microbiota, brain-gut axis, psychiatric disorders, schizophrenia, depression Received: June 15, 2017 Accepted: August 26, 2017 Published: September 27, 2017 ABSTRACT The importance of interactions between the brain and the gastrointestinal tract has been increasingly recognized in recent years. It has been proposed that dysregulation and abnormalities in the brain-gut axis contribute to the etiology of a variety of central nervous system disorders. Particularly, dysbiosis, or impaired microbiota, has been implicated in multiple neurological and psychological disorders. The present paper reviews current evidence and theories concerning the possible mechanisms by which microbiota dysfunction contributes to the pathogenesis of schizophrenia and major depressive disorder. Clinical trials that investigated the possibility of treating both illnesses by correcting and rebalancing microbiota with probiotics are also reviewed. Overall, despite the accumulated knowledge in this field, more studies are warranted and required to further our understanding of the brain-gut axis and the possibility of targeting microbiota as a treatment option for schizophrenia and major depressive disorder.
Source: Oncotarget
Language: English
Open Access status: diamond
OpenAlex ID: W2759966800
FWCI: 1.005
Cites: 73
Cited by: 83
Related to: 10